A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

NCT05445167 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids (MeSH Heading: Leiomyoma)

Interventions

DRUG: KLH-2109
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.